Skip to content

Assessing the effect of Katphala in the management of Prameha (Type 2 Diabetes Mellitus)

PHARMACOGNOSTICAL AND PHARMACO-THERAPEUTIC EVALUATION OF KATPHALA(Myrica esculenta Buch-Ham)TWAK IN THE MANAGEMENT OF PRAMEHA(TYPE 2 DIABETES MELLITUS) - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069464
Enrollment
45
Registered
2024-06-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Post Graduate Institute of Ayurveda DSRRAU Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients between the age group of 30-70 years of either sex present with clinical features of Prameha. 2. Patients having a fasting blood sugar level (FBS) greater than 126 mg/dL and less than 200 mg/dL. 3. Patients having a 2 hour post prandial blood sugar level (PPBS) greater than 200 mg/dL and less than 350 mg/dL. 4. Written consent showing willingness to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patients below 30 years and above 70 years will be excluded. 2. Pregnant and lactation mothers. 3. Known case of Type 1 Diabetes Mellitus or I. D. D. M. Patients. 4. Type 2 DM patients having insulin therapy due to secondary failure. 5. Patients suffering from the complications of DM like Ketoacidosis, Neuropathy, Nephropathy, Retinopathy and Diabetic wounds. 6. Patients suffering from any severe systemic disease, chronic infections or any active malignancy.

Design outcomes

Primary

MeasureTime frame
Changes in Fasting Blood Sugar and Post Prandial Blood SugarTimepoint: 60 DAYS

Secondary

MeasureTime frame
Changes in Glycosylated Haemoglobin (HbA1c)Timepoint: 60 DAYS

Countries

India

Contacts

Public ContactDr Chandan Singh

Post Graduate Institute of Ayurveda DSRRAU Jodhpur

foramshah8499@gmail.com9909029813

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026